Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 267-275

  Marquardt, Jens U ^a   Galle, Peter R ^a   Teufel, Andreas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Gene expression profile; Liver cancer; Molecular pathogenesis; Target therapy

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER DIAGNOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; EPIGENETICS; GENE EXPRESSION; GENETIC REGULATION; GENOME; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MEDICAL TECHNOLOGY; MOLECULAR DIAGNOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; EPIGENESIS, GENETIC; GENOMICS; HUMANS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS; PATHOLOGY, MOLECULAR; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTOME; TRANSLATIONAL MEDICAL RESEARCH;

EID: 83555162579     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.07.007     Document Type: Review

References (140)

1. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576 (Pubitemid 46890874)
2. M. Sherman Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis Semin Liver Dis 30 2010 3 16
3. V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos, and V. Vilgrain Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
4. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2010 1020 1022
5. Y.N. Park, and M.J. Kim Hepatocarcinogenesis: imaging-pathologic correlation Abdom Imaging 36 3 2011 232 243
6. M.A. Worns, and P.R. Galle Future perspectives in hepatocellular carcinoma Dig Liver Dis 42 2010 S302 309
7. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
8. A. Villanueva, and J.M. Llovet Targeted therapies for hepatocellular carcinoma Gastroenterology 140 2011 1410 1426
9. M.A. Worns, and P.R. Galle Novel inhibitors in development for hepatocellular carcinoma Expert Opin Investig Drugs 19 2010 615 629
10. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, and J. Donovan The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
11. Z. Kan, B.S. Jaiswal, J. Stinson, V. Janakiraman, D. Bhatt, and H.M. Stern Diverse somatic mutation patterns and pathway alterations in human cancers Nature 466 2010 869 873
12. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, and A. Rosenwald Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511 (Pubitemid 30082188)
13. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, and J.P. Mesirov Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
14. M. Ayers, W.F. Symmans, J. Stec, A.I. Damokosh, E. Clark, and K. Hess Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer J Clin Oncol 22 2004 2284 2293 (Pubitemid 41115384)
15. J.S. Lee, I.S. Chu, J. Heo, D.F. Calvisi, Z. Sun, and T. Roskams Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676 (Pubitemid 39265589)
16. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
17. U. McDermott, J.R. Downing, and M.R. Stratton Genomics and the continuum of cancer care N Engl J Med 364 2011 340 350
18. R.N. Aravalli, C.J. Steer, and E.N. Cressman Molecular mechanisms of hepatocellular carcinoma Hepatology 48 2008 2047 2063
19. M. Kojiro, and T. Roskams Early hepatocellular carcinoma and dysplastic nodules Semin Liver Dis 25 2005 133 142 (Pubitemid 40781066)
20. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687 (Pubitemid 44286000)
21. A. Villanueva, P. Newell, D.Y. Chiang, S.L. Friedman, and J.M. Llovet Genomics and signaling pathways in hepatocellular carcinoma Semin Liver Dis 27 2007 55 76
22. V. Kumar, N. Kato, Y. Urabe, A. Takahashi, R. Muroyama, and N. Hosono Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma Nat Genet 43 2011 455 458
23. E. Melum, A. Franke, C. Schramm, T.J. Weismuller, D.N. Gotthardt, and F.A. Offner Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci Nat Genet 43 2011 17 19
24. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
25. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
26. M. Krawczyk, R. Mullenbach, S.N. Weber, V. Zimmer, and F. Lammert Genome-wide association studies and genetic risk assessment of liver diseases Nat Rev Gastroenterol Hepatol 7 2010 669 681
27. M. Meyerson, S. Gabriel, and G. Getz Advances in understanding cancer genomes through second-generation sequencing Nat Rev Genet 11 2010 685 696
28. J.S. Lee, and S.S. Thorgeirsson Genetic profiling of human hepatocellular carcinoma Semin Liver Dis 25 2005 125 132 (Pubitemid 40781065)
29. Y. Hoshida, S. Toffanin, A. Lachenmayer, A. Villanueva, B. Minguez, and J.M. Llovet Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Semin Liver Dis 30 2010 35 51
30. T.C. Poon, N. Wong, P.B. Lai, M. Rattray, P.J. Johnson, and J.J. Sung A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data Gastroenterology 131 2006 1262 1270 (Pubitemid 44515104)
31. C.L. Keck, D.B. Zimonjic, B.Z. Yuan, S.S. Thorgeirsson, and N.C. Popescu Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines Cancer Genet Cytogenet 111 1999 37 44 (Pubitemid 29214333)
32. D.B. Zimonjic, C.L. Keck, S.S. Thorgeirsson, and N.C. Popescu Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization Hepatology 29 1999 1208 1214 (Pubitemid 29168756)
33. C.F. Chen, E.C. Hsu, K.T. Lin, P.H. Tu, H.W. Chang, and C.H. Lin Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma Hepatology 52 2010 1690 1701
34. W.H. Su, C.C. Chao, S.H. Yeh, D.S. Chen, P.J. Chen, and Y.S. Jou Onco DB. HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci Nucleic Acids Res 35 2007 D727 731
35. J.S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, and J.K. Reddy Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 2004 1306 1311 (Pubitemid 39577940)
36. L. Zender Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
37. D.B. Zimonjic, V. Ullmannova-Benson, V.M. Factor, S.S. Thorgeirsson, and N.C. Popescu Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease Cancer Genet Cytogenet 191 2009 17 26
38. H.G. Woo, E.S. Park, J.S. Lee, Y.H. Lee, T. Ishikawa, and Y.J. Kim Identification of potential driver genes in human liver carcinoma by genomewide screening Cancer Res 69 2009 4059 4066
39. J. Lamb The connectivity map: a new tool for biomedical research Nat Rev Cancer 7 2007 54 60 (Pubitemid 46020847)
40. J. Lamb, E.D. Crawford, D. Peck, J.W. Modell, I.C. Blat, and M.J. Wrobel The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935 (Pubitemid 44497995)
41. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
42. T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, and H. Jia EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461 (Pubitemid 351346853)
43. N. Iizuka Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929 (Pubitemid 36332108)
44. J.S. Lee Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
45. Q.H. Ye, L.X. Qin, M. Forgues, P. He, J.W. Kim, and A.C. Peng Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423 (Pubitemid 36460075)
46. P. Kaposi-Novak, L. Libbrecht, H.G. Woo, Y.H. Lee, N.C. Sears, and E.A. Conner Central role of c-Myc during malignant conversion in human hepatocarcinogenesis Cancer Res 69 2009 2775 2782
47. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
48. Y. Hoshida, S.M. Nijman, M. Kobayashi, J.A. Chan, J.P. Brunet, and D.Y. Chiang Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
49. J.B. Andersen, V.M. Factor, J.U. Marquardt, C. Raggi, Y.H. Lee, and D. Seo An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
50. H.G. Woo, J.H. Lee, J.H. Yoon, C.Y. Kim, H.S. Lee, and J.J. Jang Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 70 2011 3034 3041
51. Y.H. Lee, J.B. Andersen, H.T. Song, A.D. Judge, D. Seo, and T. Ishikawa Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma Cancer Res 70 21 2010 8264 8269
52. Lee YH, Judge AD, Seo D, Kitade M, Gomez-Quiroz LE, Ishikawa T, et al. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response. Oncogene 2011.
53. A. Villanueva, D.Y. Chiang, P. Newell, J. Peix, S. Thung, and C. Alsinet Pivotal role of mTOR signaling in hepatocellular carcinoma Gastroenterology 135 6 2008 1972 1973 1983. e1-11
54. A. Villanueva, Y. Hoshida, C. Battiston, V. Tovar, D. Sia, and C. Alsinet Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma Gastroenterology 140 2011 1501 1512 e1502
55. A.M. Glas, A. Floore, L.J. Delahaye, A.T. Witteveen, R.C. Pover, and N. Bakx BMC Genomics 7 2006 278
56. M.A. Cobleigh, B. Tabesh, P. Bitterman, J. Baker, M. Cronin, and M.L. Liu Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes Clin Cancer Res 11 2005 8623 8631 (Pubitemid 43005909)
57. J.A. Foekens, D. Atkins, Y. Zhang, F.C. Sweep, N. Harbeck, and A. Paradiso Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 2006 1665 1671 (Pubitemid 46622137)
58. A. Budhu, M. Forgues, Q.H. Ye, H.L. Jia, P. He, and K.A. Zanetti Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 2006 99 111 (Pubitemid 44202603)
59. G. Sherlock, T. Hernandez-Boussard, A. Kasarskis, G. Binkley, J.C. Matese, and S.S. Dwight The Stanford microarray database Nucleic Acids Res 29 2001 152 155 (Pubitemid 32054432)
60. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, and M.A. Gillette Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci USA 102 2005 15545 15550 (Pubitemid 41528093)
61. S. Buchkremer, J. Hendel, M. Krupp, A. Weinmann, K. Schlamp, and T. Maass Library of molecular associations: curating the complex molecular basis of liver diseases BMC Genomics 11 2010 189
62. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, and D. Ghosh ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6 (Pubitemid 38391943)
63. A.P. Feinberg Phenotypic plasticity and the epigenetics of human disease Nature 447 2007 433 440 (Pubitemid 46816750)
64. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2004 143 153 (Pubitemid 38198742)
65. W. Gao, Y. Kondo, L. Shen, Y. Shimizu, T. Sano, and K. Yamao Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas Carcinogenesis 29 2008 1901 1910
66. S. Lee Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis Am J Pathol 163 2003 1371 1378 (Pubitemid 37175085)
67. T.H. Um, H. Kim, B.K. Oh, M.S. Kim, K.S. Kim, and G. Jung Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis J Hepatol 54 2011 939 947
68. H. Hernandez-Vargas, M.P. Lambert, F. Le Calvez-Kelm, G. Gouysse, S. McKay-Chopin, and S.V. Tavtigian Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors PLoS One 5 2010 e9749
69. M.P. Lambert, A. Paliwal, T. Vaissiere, I. Chemin, F. Zoulim, and M. Tommasino Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake J Hepatol 54 2010 705 715
70. D.F. Calvisi, S. Ladu, A. Gorden, M. Farina, J.S. Lee, and E.A. Conner Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma J Clin Invest 117 2007 2713 2722 (Pubitemid 47494371)
71. J.S. Lee A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
72. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
73. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
74. C. Coulouarn, V.M. Factor, J.B. Andersen, M.E. Durkin, and S.S. Thorgeirsson Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties Oncogene 28 2009 3526 3536
75. J.L. Mott MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia Hepatology 50 2009 630 637
76. P.B. Dirks MicroRNAs and parallel stem cell lives Cell 138 2009 423 424
77. J. Ji, T. Yamashita, A. Budhu, M. Forgues, H.L. Jia, and C. Li Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells Hepatology 50 2009 472 480
78. S. Ma, K.H. Tang, Y.P. Chan, T.K. Lee, P.S. Kwan, and A. Castilho miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1 Cell Stem Cell 7 6 2010 694 707
79. J.U. Marquardt, V.M. Factor, and S.S. Thorgeirsson Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications J Hepatol 53 2010 568 577
80. A. Budhu, H.L. Jia, M. Forgues, C.G. Liu, D. Goldstein, and A. Lam Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907 (Pubitemid 351449681)
81. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
82. Y. Ladeiro, G. Couchy, C. Balabaud, P. Bioulac-Sage, L. Pelletier, and S. Rebouissou MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Hepatology 47 2008 1955 1963 (Pubitemid 351952843)
83. S. Toffanin, Y. Hoshida, A. Lachenmayer, A. Villanueva, L. Cabellos, and B. Minguez MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a Gastroenterology 140 2011 1618 1628 e1616
84. G. Ramsingh, D.C. Koboldt, M. Trissal, K.B. Chiappinelli, T. Wylie, and S. Koul Complete characterization of the microRNAome in a patient with acute myeloid leukemia Blood 116 2010 5316 5326
85. J.H. Schulte, T. Marschall, M. Martin, P. Rosenstiel, P. Mestdagh, and S. Schlierf Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma Nucleic Acids Res 38 2010 5919 5928
86. E.A. Eisenhauer From the molecule to the clinic - inhibiting HER2 to treat breast cancer N Engl J Med 344 2001 841 842 (Pubitemid 32222164)
87. M.S. Tsao, A. Sakurada, J.C. Cutz, C.Q. Zhu, S. Kamel-Reid, and J. Squire Erlotinib in lung cancer - molecular and clinical predictors of outcome N Engl J Med 353 2005 133 144 (Pubitemid 41058345)
88. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
89. S.S. Thorgeirsson Genomic decoding of hepatocellular carcinoma Gastroenterology 131 2006 1344 1346 (Pubitemid 44498720)
90. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339 346 (Pubitemid 35154440)
91. A. Villanueva, D.Y. Chiang, P. Newell, J. Peix, S. Thung, and C. Alsinet Pivotal role of mTOR signaling in hepatocellular carcinoma Gastroenterology 135 2008 1972 1983 e1971-1911
92. J.U. Marquardt, and S.S. Thorgeirsson Stem cells in hepatocarcinogenesis: evidence from genomic data Semin Liver Dis 30 2010 26 34
93. M. Kakarala, and M.S. Wicha Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy J Clin Oncol 26 2008 2813 2820
94. J.U. Marquardt, and S.S. Thorgeirsson Cancer stem cells and liver cancer X.W. Wang, S.S. Thorgeirsson, Molecular genetics of liver neoplasia 2011 Springer New York, Dordrecht, Heidelberg, London 279 301
95. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 2006 1253 1261 (Pubitemid 44427449)
96. P.A. Philip, M. Mooney, D. Jaffe, G. Eckhardt, M. Moore, and N. Meropol Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment J Clin Oncol 27 2009 5660 5669
97. T. Yamashita, M. Honda, K. Nio, Y. Nakamoto, H. Takamura, and T. Tani Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-fluorouracil by inducing hepatocytic differentiation Cancer Res 70 2010 4687 4697
98. T. Yamashita, J. Ji, A. Budhu, M. Forgues, W. Yang, and H.Y. Wang EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
99. B. Christ, P. Stock, and M.M. Dollinger CD13: waving the flag for a novel cancer stem cell target Hepatology 53 2011 1388 1390
100. N. Haraguchi, H. Ishii, K. Mimori, F. Tanaka, M. Ohkuma, and H.M. Kim CD13 is a therapeutic target in human liver cancer stem cells J Clin Invest 120 2010 3326 3339
101. J.B. Andersen, R. Loi, A. Perra, V.M. Factor, G.M. Ledda-Columbano, and A. Columbano Progenitor-derived hepatocellular carcinoma model in the rat Hepatology 51 4 2009 1401 1409
102. P.J. Campbell, S. Yachida, L.J. Mudie, P.J. Stephens, E.D. Pleasance, and L.A. Stebbings The patterns and dynamics of genomic instability in metastatic pancreatic cancer Nature 467 2010 1109 1113
103. S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary, and B. Fu Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 2010 1114 1117
104. S.P. Gygi, Y. Rochon, B.R. Franza, and R. Aebersold Correlation between protein and mRNA abundance in yeast Mol Cell Biol 19 1999 1720 1730 (Pubitemid 29098230)
105. S. Kozhenkov, Y. Dubinina, M. Sedova, A. Gupta, J. Ponomarenko, and M. Baitaluk Biological networks 2.0 - an integrative view of genome biology data BMC Bioinformatics 11 2010 610
106. Capturing cancer stem cells. Nat Med 2008;14:814.
107. P.A. Farazi, J. Glickman, J. Horner, and R.A. Depinho Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression Cancer Res 66 2006 4766 4773
108. K. Minouchi, S. Kaneko, and K. Kobayashi Mutation of p53 gene in regenerative nodules in cirrhotic liver J Hepatol 37 2002 231 239 (Pubitemid 34833085)
109. N. Nishida Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma Cancer Res 53 1993 368 372 (Pubitemid 23031851)
110. H.G. Woo, X.W. Wang, A. Budhu, Y.H. Kim, S.M. Kwon, and Z.Y. Tang Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma Gastroenterology 140 2011 1063 1070
111. F.Q. An Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 and [beta]-catenin Int J Cancer 93 2001 468 474
112. D.F. Calvisi, V.M. Factor, S. Ladu, E.A. Conner, and S.S. Thorgeirsson Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice Gastroenterology 126 2004 1374 1386 (Pubitemid 38552801)
113. Y. Ishizaki Immunohistochemical analysis and mutational analyses of [beta]-catenin, Axin family and APC genes in hepatocellular carcinomas Int J Oncol 24 2004 1077 1083
114. M. Hopfner Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma J Hepatol 41 2004 1008 1016 (Pubitemid 39575669)
115. Y. Ito Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma Br J Cancer 84 2001 1377 1383 (Pubitemid 32522107)
116. P.A. Philip Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer J Clin Oncol 23 2005 6657 6663 (Pubitemid 46190260)
117. S.O. Kim, J.G. Park, and Y.I. Lee Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product Cancer Res 56 1996 3831 3836 (Pubitemid 26272036)
118. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
119. S.H. Tang, D.H. Yang, W. Huang, H.K. Zhou, X.H. Lu, and G. Ye Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population Clin Cancer Res 12 2006 4171 4177
120. V. Tovar, C. Alsinet, A. Villanueva, Y. Hoshida, D.Y. Chiang, and M. Sole IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage J Hepatol 52 2011 550 559
121. P. Kaposi-Novak, J.S. Lee, L. Gomez-Quiroz, C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype J Clin Invest 116 2006 1582 1595
122. G.M. Stella, S. Benvenuti, and P.M. Comoglio Targeting the MET oncogene in cancer and metastases Expert Opin Investig Drugs 19 2010 1381 1394
123. C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067 (Pubitemid 351945572)
124. L. Mishra, R. Derynck, and B. Mishra Transforming growth factor-beta signaling in stem cells and cancer Science 310 2005 68 71 (Pubitemid 41434534)
125. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436 (Pubitemid 44050137)
126. A.M. Elsharkawy, and D.A. Mann Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis Hepatology 46 2007 590 597 (Pubitemid 47344795)
127. B. Sun, and M. Karin NF-kappaB signaling, liver disease and hepatoprotective agents Oncogene 27 2008 6228 6244
128. X.M. Li, Z.Y. Tang, G. Zhou, Y.K. Lui, and S.L. Ye Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma J Exp Clin Cancer Res 17 1998 13 17 (Pubitemid 28215959)
129. R.T. Poon, J.W. Ho, C.S. Tong, C. Lau, I.O. Ng, and S.T. Fan Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma Br J Surg 91 2004 1354 1360 (Pubitemid 39331462)
130. O. Rosmorduc, and C. Housset Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease Semin Liver Dis 30 2010 258 270
131. J. Avruch, D. Zhou, J. Fitamant, and N. Bardeesy Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development Br J Cancer 104 2011 24 32
132. A. Lachenmayer, Y. Hoshida, and J.M. Llovet Hippo tumor suppressor pathway: novel implications for the treatment of hepatocellular carcinoma Gastroenterology 139 2010 692 694
133. K.P. Lee, J.H. Lee, T.S. Kim, T.H. Kim, H.D. Park, and J.S. Byun The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc Natl Acad Sci USA 107 2010 8248 8253
134. D. Zhou, C. Conrad, F. Xia, J.S. Park, B. Payer, and Y. Yin Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438
135. S.M. Wang, L.L. Ooi, and K.M. Hui Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma Clin Cancer Res 13 2007 6275 6283 (Pubitemid 350075015)
136. S. Boyault, D.S. Rickman, A. De Reynies, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52 (Pubitemid 46144363)
137. H.G. Woo, E.S. Park, J.H. Cheon, J.H. Kim, J.S. Lee, and B.J. Park Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma Clin Cancer Res 14 2008 2056 2064 (Pubitemid 351551116)
138. S. Yoshioka, I. Takemasa, H. Nagano, N. Kittaka, T. Noda, and H. Wada Molecular prediction of early recurrence after resection of hepatocellular carcinoma Eur J Cancer 45 2009 881 889
139. Y. Hoshida, S.M. Nijman, M. Kobayashi, J.A. Chan, J.P. Brunet, and D.Y. Chiang Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
140. S. Roessler, H.L. Jia, A. Budhu, M. Forgues, Q.H. Ye, and J.S. Lee A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res 70 2010 10202 10212